# Axillary Reverse Mapping Using Near-infrared Imaging in Invasive Breast Cancer: Predictors of Nodal Positivity

> **NCT02994225** · NA · COMPLETED · sponsor: **Gustave Roussy, Cancer Campus, Grand Paris** · enrollment: 120 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Indocyanine Green

## Key facts

- **NCT ID:** NCT02994225
- **Lead sponsor:** Gustave Roussy, Cancer Campus, Grand Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-10
- **Primary completion:** 2019-06-07
- **Final completion:** 2019-08-05
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2022-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02994225

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02994225, "Axillary Reverse Mapping Using Near-infrared Imaging in Invasive Breast Cancer: Predictors of Nodal Positivity". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02994225. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*